Home LiteratureArticle Details
PMID: 10677500 Published · ppublish English Journal Article

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ

Abstract

We have generated RANK (receptor activator of NF-kappaB) nullizygous mice to determine the molecular genetic interactions between osteoprotegerin, osteoprotegerin ligand, and RANK during bone resorption and remodeling processes. RANK(-/-) mice lack osteoclasts and have a profound defect in bone resorption and remodeling and in the development of the cartilaginous growth plates of endochondral bone. The osteopetrosis observed in these mice can be reversed by transplantation of bone marrow from rag1(-/-) (recombinase activating gene 1) mice, indicating that RANK(-/-) mice have an intrinsic defect in osteoclast function. Calciotropic hormones and proresorptive cytokines that are known to induce bone resorption in mice and human were administered to RANK(-/-) mice without inducing hypercalcemia, although tumor necrosis factor alpha treatment leads to the rare appearance of osteoclast-like cells near the site of injection. Osteoclastogenesis can be initiated in RANK(-/-) mice by transfer of the RANK cDNA back into hematopoietic precursors, suggesting a means to critically evaluate RANK structural features required for bone resorption. Together these data indicate that RANK is the intrinsic cell surface determinant that mediates osteoprotegerin ligand effects on bone resorption and remodeling as well as the physiological and pathological effects of calciotropic hormones and proresorptive cytokines.

MeSH Terms
Animals Bone Remodeling/genetics Bone Resorption/genetics Bone and Bones/metabolism Calcium/metabolism Carrier Proteins/genetics,metabolism,pharmacology Cell Differentiation/genetics Cytokines/pharmacology Gene Targeting Gene Transfer Techniques Growth Plate/pathology Membrane Glycoproteins/genetics,metabolism,pharmacology Mice Mice, Knockout Osteoclasts/pathology Osteogenesis Osteopetrosis/genetics,pathology RANK Ligand Receptor Activator of Nuclear Factor-kappa B Retroviridae/genetics
Chemicals
Carrier Proteins Cytokines Membrane Glycoproteins RANK Ligand Receptor Activator of Nuclear Factor-kappa B TNFRSF11A protein, human TNFSF11 protein, human Tnfrsf11a protein, mouse Tnfsf11 protein, mouse Calcium
Authors & Affiliations
23 authors, click to expand affiliations / ORCID
Li J
Departments of Cell Biology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
Sarosi I
Yan X Q
Morony S
Capparelli C
Tan H L
McCabe S
Elliott R
Scully S
Van G
Kaufman S
Juan S C
Sun Y
Tarpley J
Martin L
Christensen K
McCabe J
Kostenuik P
Hsu H
Fletcher F
Dunstan C R
Lacey D L
Boyle W J
References (29)
29 references, click to expand
  1. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.
    Science. 1994 Oct 21;266(5184):443-8 PMID: 7939685
  2. Bone and haematopoietic defects in mice lacking c-fos.
    Nature. 1992 Dec 24-31;360(6406):741-5 PMID: 1465144
  3. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses.
    Immunity. 1996 Nov;5(5):407-15 PMID: 8934568
  4. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
    Cell. 1997 Apr 18;89(2):309-19 PMID: 9108485
  5. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.
    J Biol Chem. 1997 Oct 3;272(40):25190-4 PMID: 9312132
  6. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.
    Nat Med. 1997 Nov;3(11):1285-9 PMID: 9359707
  7. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
    Nature. 1997 Nov 13;390(6656):175-9 PMID: 9367155
  8. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
    Immunity. 1997 Nov;7(5):715-25 PMID: 9390694
  9. Requirement for NF-kappaB in osteoclast and B-cell development.
    Genes Dev. 1997 Dec 15;11(24):3482-96 PMID: 9407039
  10. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602 PMID: 9520411
  11. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
    Cell. 1998 Apr 17;93(2):165-76 PMID: 9568710
  12. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
    Genes Dev. 1998 May 1;12(9):1260-8 PMID: 9573043
  13. Functional analysis of the PTH/PTHrP network of ligands and receptors.
    Recent Prog Horm Res. 1998;53:283-301; discussion 301-3 PMID: 9769712
  14. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    J Biol Chem. 1998 Oct 23;273(43):28355-9 PMID: 9774460
  15. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13030-5 PMID: 9789035
  16. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    J Biol Chem. 1998 Dec 18;273(51):34120-7 PMID: 9852070
  17. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.
    Biochem Biophys Res Commun. 1998 Dec 18;253(2):395-400 PMID: 9878548
  18. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
    Nature. 1999 Jan 28;397(6717):315-23 PMID: 9950424
  19. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    J Biol Chem. 1999 Mar 19;274(12):7724-31 PMID: 10075662
  20. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
    Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5 PMID: 10097072
  21. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
    Genes Dev. 1999 Apr 15;13(8):1015-24 PMID: 10215628
  22. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9803-8 PMID: 10449775
  23. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
    J Bone Miner Res. 1999 Sep;14(9):1478-85 PMID: 10469275
  24. RANK is essential for osteoclast and lymph node development.
    Genes Dev. 1999 Sep 15;13(18):2412-24 PMID: 10500098
  25. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
    J Bone Miner Res. 2000 Jan;15(1):2-12 PMID: 10646108
  26. Role of osteoblasts in hormonal control of bone resorption--a hypothesis.
    Calcif Tissue Int. 1981;33(4):349-51 PMID: 6271355
  27. Effects of interleukin-1 on bone turnover in normal mice.
    Endocrinology. 1989 Sep;125(3):1142-50 PMID: 2788075
  28. Modulation of osteoclast differentiation.
    Endocr Rev. 1992 Feb;13(1):66-80 PMID: 1555533
  29. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.
    Nat Med. 1996 Aug;2(8):876-82 PMID: 8705856
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-02-15
Pages
1566-71
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC26475
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]